Celexa vs. Lexapro: What's the Difference Between Them?

Celexa (citalopram) and Lexapro (escitalopram) are closer relatives than almost any other pair of antidepressants. Lexapro contains only one of the two mirror-image forms of the molecule in Celexa. So people often ask whether Lexapro is simply an improved Celexa, and whether Celexa’s heart warning follows it.

The real answer is more interesting than a yes or no. This post sets the two side by side using their FDA labels, FDA safety notices and the research. It’s meant as background for a talk with your provider, not a recommendation.

One Medication Made From the Other

Both are SSRIs, or selective serotonin reuptake inhibitors, and both are sold under their brand names and as generics. Celexa was first approved in the U.S. in 1998 and Lexapro in 2002, according to their FDA labels (Celexa, Lexapro).

The link between them is chemistry. Citalopram is what chemists call a racemic mixture: an equal mix of two forms of the same molecule that are mirror images of each other, like a left and a right hand. Escitalopram is only one of those two forms, called the S-form. Lexapro’s label calls escitalopram the active isomer of citalopram, which is why the two behave so much alike.

Because they’re so closely related, their labels share most of the same warnings:

• The boxed warning about suicidal thoughts and behaviors in people up to age 24 (full wording in the comparison below).
• Serotonin syndrome, a rare but serious reaction, and a higher risk of bleeding.
• Setting off mania or hypomania in people with bipolar disorder.
• Low sodium, sexual side effects, symptoms if stopped abruptly, and a rare eye problem called angle-closure glaucoma.

Neither can be taken with MAOIs (an older group of antidepressants) or with pimozide, and neither should be started in someone being treated with linezolid (an antibiotic) or intravenous methylene blue, which act as MAOIs.

What Each One Is Approved to Treat

For adults, the FDA-approved uses differ:

• Celexa (citalopram): major depressive disorder.
• Lexapro (escitalopram): major depressive disorder and generalized anxiety disorder.

Lexapro is also approved for some uses in children and teens, and Celexa isn’t; we see adults 18 to 65.

Approval for one condition doesn’t mean a medication can’t help with others; it reflects what was formally studied. Providers may prescribe an approved medication for another use when they judge it medically appropriate, which is called off-label use. Our anxiety disorders guide explains how the different anxiety conditions differ.

The Heart Rhythm Warning on Celexa’s Label

QT is a stretch of the heartbeat measured on an electrocardiogram (ECG). A long QT interval can upset the timing of the heartbeat and cause sudden, fast heart rhythms.

In 2011, the FDA warned that citalopram shouldn’t be used above a set maximum dose because it can cause abnormal changes in the heart’s electrical activity, and noted that studies hadn’t shown more benefit for depression above that dose. That 2011 notice also set a lower maximum for people over 60, people with liver problems, people whose bodies clear citalopram slowly, and people taking cimetidine. A 2012 revision changed the advice for people born with long QT syndrome from “contraindicated” to “not recommended,” and said that if citalopram must be used in people at higher risk, ECG or electrolyte monitoring should be done.

Celexa’s current label lists QT prolongation and torsade de pointes (a dangerous heart rhythm) in its numbered Warnings and Precautions section. It says Celexa causes QT prolongation that increases with the dose, and it:

• Sets a maximum dose because of the QT risk, and a lower maximum for people over 60, people with liver problems, people whose bodies clear it slowly because of their genes (explained below), and people taking medicines that block the liver enzyme CYP2C19.
• Says Celexa should be avoided in people with congenital long QT syndrome (long QT present from birth), a slow heart rate, low potassium or magnesium, a recent heart attack or uncompensated heart failure, and in people taking other medications that prolong QT, unless the benefits outweigh the risks for that person.
• Recommends checking potassium and magnesium before starting, and from time to time afterward, in people at risk of low levels, and correcting low levels first.
• Recommends ECG monitoring for people in those higher-risk groups if Celexa is used anyway.
• Says to stop Celexa if QT measurements stay above a set limit.

The label tells patients to contact their provider right away if they feel faint, lose consciousness or have heart palpitations.

Does Lexapro Avoid the Heart Rhythm Problem?

You may have heard that Lexapro sidesteps Celexa’s heart warning. The labels and the research point in somewhat different directions.

Lexapro’s label has no QT item in its Warnings and Precautions section and no QT-related dose limits. It does describe a small QT increase in a study of healthy volunteers, larger at a dose above the approved range, and lists QT prolongation and torsade de pointes among reports after marketing. It also notes that Lexapro hasn’t been systematically studied in people with a recent heart attack or unstable heart disease.

Escitalopram also prolongs QT in a dose-related way, though usually less than citalopram at comparable doses. In the Lexapro label’s study of healthy volunteers, the QT increase was larger at the higher dose. Here’s what the main studies found:

• A 2013 U.S. review of the published studies found possible dose-related QT prolongation with escitalopram. It concluded that when citalopram is avoided because of heart rhythm risk factors, escitalopram is probably not the lowest-risk substitute.
• A 2013 U.S. study of records from 38,397 adults linked higher doses of both citalopram and escitalopram to longer QT.
• An international study of reports to the World Health Organization’s drug safety database found a QT signal for citalopram and escitalopram, and not for the other serotonin reuptake inhibitors it looked at.
• A 2026 study of 4,921 hospital patients found modestly fewer QT events with sertraline than with citalopram or escitalopram, which it grouped together. That advantage showed up with one way of measuring QT but not with another correction formula, and the authors favored ECG- and electrolyte-guided prescribing over automatic switching.
• In a study of older adults in Ontario, Canada, an international study, starting citalopram was linked to a small rise in hospital visits for dangerous heart rhythms, while starting escitalopram wasn’t.
• A 2026 analysis of trial data, an international study, found that escitalopram raised QT modestly compared with placebo and that antidepressants weren’t linked to early major heart problems. Citalopram wasn’t part of that analysis.

How much Celexa’s warning matters in everyday use is debated. A 2013 study of Veterans Health Administration records found no higher risk of dangerous heart rhythms or death at citalopram doses above the label’s maximum, and its authors questioned whether the warning was still needed. A 2011 study of Medicaid records found citalopram’s risk of sudden cardiac death and dangerous rhythms close to that of paroxetine, the comparison medication. A 2016 study of VA patients found that after the warning, lowering citalopram doses was followed by more hospitalizations, with no drop in deaths. These were observational studies, which can’t prove cause or rule out risk. Regulators outside the U.S. haven’t all drawn the line in the same place either: the UK’s medicines regulator (international) also set a lower maximum escitalopram dose for older adults because of QT. That’s one more sign the labels and the research don’t fully line up. The FDA warning hasn’t changed: it’s still on Celexa’s current label, and providers follow it, including its dose limits and its advice on heart checks for people at higher risk.

For most people the absolute risk is low, and it depends on the dose and on personal risk factors, such as other medications, a heart condition, or low potassium or magnesium. What matters most is telling your provider about any heart rhythm problem, fainting, a family history of long QT, and everything else you take. If you have a heart condition, ask your primary care provider or cardiologist whether an ECG makes sense.

Liver Enzymes, Genes and Other Medicines

The body clears both medications mainly through liver enzymes, including one called CYP2C19. How the labels handle that enzyme is one of the clearest practical differences between them.

• Celexa: People whose genes make CYP2C19 work poorly (called “poor metabolizers”) have higher citalopram levels, so the label sets a lower maximum dose for them. It does the same for people taking medicines that block CYP2C19, naming cimetidine and omeprazole, two acid reducers, as examples.
• Lexapro: The label names the same enzymes, but says that because escitalopram is cleared by several of them, blocking one may not slow its clearance much. It sets no CYP2C19 dose limit. For cimetidine, it cites a study done with citalopram and calls the significance unknown. Genetics still matter for both: Lexapro’s label notes that people who clear escitalopram slowly reach higher levels, even though only Celexa’s label sets a CYP2C19 dose limit.

Both labels also warn about combining either one with other serotonin-affecting medications, and with aspirin, anti-inflammatory pain relievers or blood thinners. A pharmacist can run your full medication list against either one.

Your CYP2C19 status can be checked with pharmacogenetic testing, which can show how your body processes some medications; it doesn’t choose a medication for you. A 2023 pharmacogenetics guideline (CPIC) gives recommendations for using CYP2C19 results to help inform prescribing for SSRIs, including citalopram and escitalopram. Your provider can tell you whether testing would help in your situation.

Is Lexapro More Effective Than Celexa?

Some research favors escitalopram, but how much weight it can bear is uncertain.

Studies favoring escitalopram. A Cochrane review (international) found escitalopram more effective than citalopram for response and remission in short-term treatment of depression, though the remission result was driven largely by one trial. Its authors cautioned that drug-company sponsorship of the trials could have overstated the effect. The largest analysis, Cipriani and colleagues in 2018, pooled 522 trials of 21 antidepressants. In its head-to-head trials, escitalopram was listed among the more effective medications and citalopram wasn’t, while both were listed among the better tolerated (full text).

Studies finding little difference. A review funded by the U.S. Agency for Healthcare Research and Quality, covering 234 studies of newer antidepressants, found no clinically relevant differences in how well they worked for depression. It concluded that the evidence doesn’t justify recommending one over another on effectiveness alone.

The Cipriani authors rated the certainty of their evidence as moderate to very low. The fair summary is that escitalopram may have a small edge in some analyses, the size of that edge is uncertain, and research averages can’t tell you how one person will respond.

Side Effects and Taking Them Together

Side effects overlap heavily, and our post on common SSRI side effects goes through them. The labels list different “most common” side effects, but Celexa’s label notes that side effect rates from one medication’s trials can’t be directly compared with another’s.

For example, Celexa’s label names one side effect, delayed ejaculation, as meeting its “most common” threshold, while Lexapro’s lists several, including insomnia, ejaculation disorder (mainly delayed ejaculation), nausea, sweating, tiredness, sleepiness, lower sex drive and difficulty reaching orgasm. Because the trials were different, that doesn’t show that Celexa causes fewer side effects.

Both labels tell prescribers to ask about sexual function before treatment and about changes during it, since people don’t always mention them. Our post on sexual side effects of antidepressants covers what can help.

Don’t take them together. Lexapro’s label says that because escitalopram is the active isomer of citalopram, the two shouldn’t be taken together. Taking both would mean doubling up on the same active ingredient, and combining serotonin-affecting medications raises the risk of serotonin syndrome. If you’re switching from one to the other, make sure an old prescription isn’t still being refilled.

How Long Do Celexa and Lexapro Take to Work?

Similar, as far as studies show. NIMH says antidepressants usually take 4 to 8 weeks to work, and that problems with sleep, appetite, energy and concentration often improve before mood lifts. MedlinePlus says it may take several weeks to notice the full benefit of citalopram and of escitalopram. The Cochrane review above had no head-to-head data on early response for these two.

The early weeks can be the hardest part, since side effects may show up before any benefit. Our post on feeling worse before you feel better walks through that stretch, and when to consider stopping a medication covers how to come off one thoughtfully. Both labels advise lowering the dose gradually rather than stopping abruptly when possible. Please don’t stop a medication on your own; some can cause withdrawal symptoms or a return of symptoms if stopped suddenly.

How the Choice Usually Gets Made

With no proven winner, the decision usually rests on your history and health rather than on a ranking:

• What’s being treated. For generalized anxiety disorder, Lexapro has the FDA approval and Celexa doesn’t.
• Your heart and your other medications. A heart rhythm problem, a recent heart attack, low potassium or magnesium, or a medicine that prolongs QT matters for both, and Celexa’s label is the more restrictive of the two.
• Age and liver health. Celexa’s label sets a lower maximum dose for people over 60 and for people with liver problems. For most older adults and for people with liver problems, Lexapro’s label recommends staying at the usual starting dose rather than going higher.
• Medicines that block CYP2C19, such as some acid reducers, and any genetic test results you already have.
• What you’ve taken before, and how it went.
• Pregnancy or breastfeeding plans. Both labels discuss pregnancy risks, such as breathing and adjustment problems in newborns after exposure late in pregnancy and bleeding after delivery, so plan with your provider. Both also describe reports of effects such as restlessness, sleepiness or poor feeding in some infants exposed through breast milk. Our post on treating depression while breastfeeding has more.

If you’re comparing other options too, our post on Lexapro vs. Zoloft looks at a different pair, and Lexapro vs. Prozac at another. It’s common for the first medication not to be the last one, and why finding the right medication can take time explains what usually comes next.

Looking for a psychiatrist in New Jersey to talk through antidepressant options? Our providers are board-certified psychiatric nurse practitioners (PMHNPs), who provide psychiatric evaluation and medication management. Our depression guide covers the bigger picture of treatment.

Frequently Asked Questions

Is Lexapro just a stronger version of Celexa?

Not exactly. Escitalopram is one of the two mirror-image forms that make up citalopram, the one Lexapro’s label calls the active isomer. The two are prescribed in different dose ranges, so the numbers on the bottle don’t tell you which is stronger. Some studies favor escitalopram slightly, but the difference is uncertain.

Is Lexapro better than Celexa for anxiety?

Lexapro is FDA-approved for generalized anxiety disorder, and Celexa isn’t approved for any anxiety disorder. Providers sometimes use a medication off-label when they judge it medically appropriate. That decision depends on the type of anxiety, your history with medication and anything else you take.

Does Lexapro have the same heart warning as Celexa?

Not on its label. Celexa’s label has a QT warning with dose limits, and Lexapro’s doesn’t, though it describes a small QT effect and reports after marketing. Research finds a QT signal for both, so tell your provider about any heart rhythm problem, fainting or family history of long QT.

Why does age matter more for Celexa?

Celexa’s label sets a lower maximum dose for people over 60, because citalopram levels tend to run higher with age and higher levels raise the QT risk. Lexapro’s label recommends that most older adults stay at the usual starting dose.

Can I switch from Celexa to Lexapro?

People do switch between them, and your provider can plan it with you. Lexapro’s label says the two shouldn’t be taken together, so the plan covers how to move from one to the other. Lexapro also shouldn’t be used by people allergic to citalopram, and the doses aren’t milligram-for-milligram, so your provider handles the switch. Please don’t stop a medication on your own; some can cause withdrawal symptoms or a return of symptoms if stopped suddenly.

Does Lexapro work faster than Celexa?

There’s no good evidence that it does. Antidepressants usually take 4 to 8 weeks to work, according to NIMH, and a Cochrane review had no head-to-head data on early response for these two.

If you’re on one of these and wondering about the other, a psychiatric evaluation is a good place to begin, and medication management gives you regular follow-ups to adjust the plan as you go.

This article is for general educational purposes only. It does not constitute medical advice, does not establish a provider-patient relationship, and is not a substitute for individual evaluation, diagnosis, or treatment by a qualified clinician. If you’re in crisis or thinking about harming yourself, call or text 988 (Suicide & Crisis Lifeline), any time, day or night. In an emergency, call 911 or go to the nearest emergency room.